Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) mRNA Vaccines & Therapeutics Market 2018, Forecast to 2023

Publisher Name :
Date: 17-Aug-2018
No. of pages: 137

mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.

Scope of the Report:

This report focuses on the mRNA Vaccines & Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

mRNA Vaccines & Therapeutics is in the development stage and there is no use in the market. The fastest research is Clinical phrase II, such as AGS-004 of Argos Therapeutics, SB-FIX, SB-318, SB-913 of Sangamo Therapeutics. The major application of mRNA Vaccines & Therapeutics is for infectious disease, cancer and others. And infectious disease and cancer are the major applications.

Since the product still in development stage, so companies rely mainly on investment or cooperation to obtain funding to continue research and development.

The research of mRNA Vaccines & Therapeutics to treat infectious disease, cancer and others. The expenses on infectious disease is the most, with the market share of 46% in 2017.

The worldwide market for mRNA Vaccines & Therapeutics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Moderna Therapeutics

- CureVac

- Translate Bio

- BioNTech

- Sangamo Therapeutics

- Argos Therapeutics

- In-Cell-Art

- eTheRNA

- Ethris

- Tiba Biotechnology

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Standardization Of Cancer Treatment MRNA Vaccine

- Individualized Cancer Treatment MRNA Vaccine

- Infectious Disease Treatment MRNA Vaccine

- Infection Prevention MRNA Vaccine

Market Segment by Applications, can be divided into

- Infectious Disease

- Cancer

- Other

There are 15 Chapters to deeply display the global mRNA Vaccines & Therapeutics market.

Chapter 1, to describe mRNA Vaccines & Therapeutics Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of mRNA Vaccines & Therapeutics, with sales, revenue, and price of mRNA Vaccines & Therapeutics, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of mRNA Vaccines & Therapeutics, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, mRNA Vaccines & Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe mRNA Vaccines & Therapeutics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) mRNA Vaccines & Therapeutics Market 2018, Forecast to 2023

Table of Contents

1 Market Overview
1.1 mRNA Vaccines & Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 Standardization Of Cancer Treatment MRNA Vaccine
1.2.2 Individualized Cancer Treatment MRNA Vaccine
1.2.3 Infectious Disease Treatment MRNA Vaccine
1.2.4 Infection Prevention MRNA Vaccine
1.3 Market Analysis by Applications
1.3.1 Infectious Disease
1.3.2 Cancer
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Moderna Therapeutics
2.1.1 Business Overview
2.1.1.1 Moderna Therapeutics Description
2.1.1.2 Moderna Therapeutics Headquarter, Main Business and Finance Overview
2.1.2 Moderna Therapeutics mRNA Vaccines & Therapeutics Product Introduction
2.1.2.1 mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
2.1.2.2 mRNA Vaccines & Therapeutics Product Information
2.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Moderna Therapeutics mRNA Vaccines & Therapeutics Market Share in 2017
2.2 CureVac
2.2.1 Business Overview
2.2.1.1 CureVac Description
2.2.1.2 CureVac Headquarter, Main Business and Finance Overview
2.2.2 CureVac mRNA Vaccines & Therapeutics Product Introduction
2.2.2.1 mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
2.2.2.2 mRNA Vaccines & Therapeutics Product Information
2.2.3 CureVac mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 CureVac mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global CureVac mRNA Vaccines & Therapeutics Market Share in 2017
2.3 Translate Bio
2.3.1 Business Overview
2.3.1.1 Translate Bio Description
2.3.1.2 Translate Bio Headquarter, Main Business and Finance Overview
2.3.2 Translate Bio mRNA Vaccines & Therapeutics Product Introduction
2.3.2.1 mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
2.3.2.2 mRNA Vaccines & Therapeutics Product Information
2.3.3 Translate Bio mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Translate Bio mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Translate Bio mRNA Vaccines & Therapeutics Market Share in 2017
2.4 BioNTech
2.4.1 Business Overview
2.4.1.1 BioNTech Description
2.4.1.2 BioNTech Headquarter, Main Business and Finance Overview
2.4.2 BioNTech mRNA Vaccines & Therapeutics Product Introduction
2.4.2.1 mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
2.4.2.2 mRNA Vaccines & Therapeutics Product Information
2.4.3 BioNTech mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 BioNTech mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global BioNTech mRNA Vaccines & Therapeutics Market Share in 2017
2.5 Sangamo Therapeutics
2.5.1 Business Overview
2.5.1.1 Sangamo Therapeutics Description
2.5.1.2 Sangamo Therapeutics Headquarter, Main Business and Finance Overview
2.5.2 Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Introduction
2.5.2.1 mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
2.5.2.2 mRNA Vaccines & Therapeutics Product Information
2.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Sangamo Therapeutics mRNA Vaccines & Therapeutics Market Share in 2017
2.6 Argos Therapeutics
2.6.1 Business Overview
2.6.1.1 Argos Therapeutics Description
2.6.1.2 Argos Therapeutics Headquarter, Main Business and Finance Overview
2.6.2 Argos Therapeutics mRNA Vaccines & Therapeutics Product Introduction
2.6.2.1 mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
2.6.2.2 mRNA Vaccines & Therapeutics Product Information
2.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Argos Therapeutics mRNA Vaccines & Therapeutics Market Share in 2017
2.7 In-Cell-Art
2.7.1 Business Overview
2.7.1.1 In-Cell-Art Description
2.7.1.2 In-Cell-Art Headquarter, Main Business and Finance Overview
2.7.2 In-Cell-Art mRNA Vaccines & Therapeutics Product Introduction
2.7.2.1 mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
2.7.2.2 mRNA Vaccines & Therapeutics Product Information
2.7.3 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global In-Cell-Art mRNA Vaccines & Therapeutics Market Share in 2017
2.8 eTheRNA
2.8.1 Business Overview
2.8.1.1 eTheRNA Description
2.8.1.2 eTheRNA Headquarter, Main Business and Finance Overview
2.8.2 eTheRNA mRNA Vaccines & Therapeutics Product Introduction
2.8.2.1 mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
2.8.2.2 mRNA Vaccines & Therapeutics Product Information
2.8.3 eTheRNA mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 eTheRNA mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global eTheRNA mRNA Vaccines & Therapeutics Market Share in 2017
2.9 Ethris
2.9.1 Business Overview
2.9.1.1 Ethris Description
2.9.1.2 Ethris Headquarter, Main Business and Finance Overview
2.9.2 Ethris mRNA Vaccines & Therapeutics Product Introduction
2.9.2.1 mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
2.9.2.2 mRNA Vaccines & Therapeutics Product Information
2.9.3 Ethris mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Ethris mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Ethris mRNA Vaccines & Therapeutics Market Share in 2017
2.10 Tiba Biotechnology
2.10.1 Business Overview
2.10.1.1 Tiba Biotechnology Description
2.10.1.2 Tiba Biotechnology Headquarter, Main Business and Finance Overview
2.10.2 Tiba Biotechnology mRNA Vaccines & Therapeutics Product Introduction
2.10.2.1 mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
2.10.2.2 mRNA Vaccines & Therapeutics Product Information
2.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global Tiba Biotechnology mRNA Vaccines & Therapeutics Market Share in 2017
3 Global mRNA Vaccines & Therapeutics Market Competition, by Manufacturer
3.1 Global mRNA Vaccines & Therapeutics Sales and Market Share by Manufacturer (2016-2017)
3.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global mRNA Vaccines & Therapeutics Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 mRNA Vaccines & Therapeutics Manufacturer Market Share in 2017
3.4.2 Top 5 mRNA Vaccines & Therapeutics Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global mRNA Vaccines & Therapeutics Market Analysis by Regions
4.1 Global mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Regions
4.1.1 Global mRNA Vaccines & Therapeutics Sales by Regions (2013-2018)
4.1.2 Global mRNA Vaccines & Therapeutics Revenue by Regions (2013-2018)
4.2 North America mRNA Vaccines & Therapeutics Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe mRNA Vaccines & Therapeutics Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific mRNA Vaccines & Therapeutics Sales, Revenue and Growth Rate (2013-2018)
4.5 South America mRNA Vaccines & Therapeutics Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa mRNA Vaccines & Therapeutics Sales, Revenue and Growth Rate (2013-2018)
5 North America mRNA Vaccines & Therapeutics by Countries, Type, Application and Manufacturers
5.1 North America mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Countries
5.1.1 North America mRNA Vaccines & Therapeutics Sales by Countries (2013-2018)
5.1.2 North America mRNA Vaccines & Therapeutics Revenue by Countries (2013-2018)
5.1.3 United States mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
5.1.4 Canada mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
5.1.5 Mexico mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
5.2 North America mRNA Vaccines & Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America mRNA Vaccines & Therapeutics Sales by Manufacturers (2016-2017)
5.2.2 North America mRNA Vaccines & Therapeutics Revenue by Manufacturers (2016-2017)
5.3 North America mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America mRNA Vaccines & Therapeutics Sales and Sales Share by Type (2013-2018)
5.3.2 North America mRNA Vaccines & Therapeutics Revenue and Revenue Share by Type (2013-2018)
5.4 North America mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America mRNA Vaccines & Therapeutics Sales and Sales Share by Application (2013-2018)
5.4.2 North America mRNA Vaccines & Therapeutics Revenue and Revenue Share by Application (2013-2018)
6 Europe mRNA Vaccines & Therapeutics by Countries, Type, Application and Manufacturers
6.1 Europe mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Countries
6.1.1 Europe mRNA Vaccines & Therapeutics Sales by Countries (2013-2018)
6.1.2 Europe mRNA Vaccines & Therapeutics Revenue by Countries (2013-2018)
6.1.3 Germany mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
6.1.4 UK mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
6.1.5 France mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
6.1.6 Russia mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
6.1.7 Italy mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
6.2 Europe mRNA Vaccines & Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe mRNA Vaccines & Therapeutics Sales by Manufacturers (2016-2017)
6.2.2 Europe mRNA Vaccines & Therapeutics Revenue by Manufacturers (2016-2017)
6.3 Europe mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe mRNA Vaccines & Therapeutics Sales and Sales Share by Type (2013-2018)
6.3.2 Europe mRNA Vaccines & Therapeutics Revenue and Revenue Share by Type (2013-2018)
6.4 Europe mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe mRNA Vaccines & Therapeutics Sales and Sales Share by Application (2013-2018)
6.4.2 Europe mRNA Vaccines & Therapeutics Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific mRNA Vaccines & Therapeutics by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales by Countries (2013-2018)
7.1.2 Asia-Pacific mRNA Vaccines & Therapeutics Revenue by Countries (2013-2018)
7.1.3 China mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
7.1.4 Japan mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
7.1.5 Korea mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
7.1.6 India mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific mRNA Vaccines & Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific mRNA Vaccines & Therapeutics Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific mRNA Vaccines & Therapeutics Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific mRNA Vaccines & Therapeutics Revenue and Revenue Share by Application (2013-2018)
8 South America mRNA Vaccines & Therapeutics by Countries, Type, Application and Manufacturers
8.1 South America mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Countries
8.1.1 South America mRNA Vaccines & Therapeutics Sales by Countries (2013-2018)
8.1.2 South America mRNA Vaccines & Therapeutics Revenue by Countries (2013-2018)
8.1.3 Brazil mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
8.1.4 Argentina mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
8.1.5 Colombia mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
8.2 South America mRNA Vaccines & Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America mRNA Vaccines & Therapeutics Sales by Manufacturers (2016-2017)
8.2.2 South America mRNA Vaccines & Therapeutics Revenue by Manufacturers (2016-2017)
8.3 South America mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America mRNA Vaccines & Therapeutics Sales and Sales Share by Type (2013-2018)
8.3.2 South America mRNA Vaccines & Therapeutics Revenue and Revenue Share by Type (2013-2018)
8.4 South America mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America mRNA Vaccines & Therapeutics Sales and Sales Share by Application (2013-2018)
8.4.2 South America mRNA Vaccines & Therapeutics Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa mRNA Vaccines & Therapeutics by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales by Countries (2013-2018)
9.1.2 Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
9.1.4 UAE mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
9.1.5 Egypt mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
9.1.6 Nigeria mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
9.1.7 South Africa mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa mRNA Vaccines & Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa mRNA Vaccines & Therapeutics Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa mRNA Vaccines & Therapeutics Revenue and Revenue Share by Application (2013-2018)
10 Global mRNA Vaccines & Therapeutics Market Segment by Type
10.1 Global mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global mRNA Vaccines & Therapeutics Sales and Market Share by Type (2013-2018)
10.1.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 Standardization Of Cancer Treatment MRNA Vaccine Sales Growth and Price
10.2.1 Global Standardization Of Cancer Treatment MRNA Vaccine Sales Growth (2013-2018)
10.2.2 Global Standardization Of Cancer Treatment MRNA Vaccine Price (2013-2018)
10.3 Individualized Cancer Treatment MRNA Vaccine Sales Growth and Price
10.3.1 Global Individualized Cancer Treatment MRNA Vaccine Sales Growth (2013-2018)
10.3.2 Global Individualized Cancer Treatment MRNA Vaccine Price (2013-2018)
10.4 Infectious Disease Treatment MRNA Vaccine Sales Growth and Price
10.4.1 Global Infectious Disease Treatment MRNA Vaccine Sales Growth (2013-2018)
10.4.2 Global Infectious Disease Treatment MRNA Vaccine Price (2013-2018)
10.5 Infection Prevention MRNA Vaccine Sales Growth and Price
10.5.1 Global Infection Prevention MRNA Vaccine Sales Growth (2013-2018)
10.5.2 Global Infection Prevention MRNA Vaccine Price (2013-2018)
11 Global mRNA Vaccines & Therapeutics Market Segment by Application
11.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2013-2018)
11.2 Infectious Disease Sales Growth (2013-2018)
11.3 Cancer Sales Growth (2013-2018)
11.4 Other Sales Growth (2013-2018)
12 mRNA Vaccines & Therapeutics Market Forecast (2018-2023)
12.1 Global mRNA Vaccines & Therapeutics Sales, Revenue and Growth Rate (2018-2023)
12.2 mRNA Vaccines & Therapeutics Market Forecast by Regions (2018-2023)
12.2.1 North America mRNA Vaccines & Therapeutics Market Forecast (2018-2023)
12.2.2 Europe mRNA Vaccines & Therapeutics Market Forecast (2018-2023)
12.2.3 Asia-Pacific mRNA Vaccines & Therapeutics Market Forecast (2018-2023)
12.2.4 South America mRNA Vaccines & Therapeutics Market Forecast (2018-2023)
12.2.5 Middle East and Africa mRNA Vaccines & Therapeutics Market Forecast (2018-2023)
12.3 mRNA Vaccines & Therapeutics Market Forecast by Type (2018-2023)
12.3.1 Global mRNA Vaccines & Therapeutics Sales Forecast by Type (2018-2023)
12.3.2 Global mRNA Vaccines & Therapeutics Market Share Forecast by Type (2018-2023)
12.4 mRNA Vaccines & Therapeutics Market Forecast by Application (2018-2023)
12.4.1 Global mRNA Vaccines & Therapeutics Sales Forecast by Application (2018-2023)
12.4.2 Global mRNA Vaccines & Therapeutics Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure mRNA Vaccines & Therapeutics Picture
Table Product Specifications of mRNA Vaccines & Therapeutics
Figure Global mRNA Vaccines & Therapeutics CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global mRNA Vaccines & Therapeutics CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of mRNA Vaccines & Therapeutics by Types in 2017
Figure Standardization Of Cancer Treatment MRNA Vaccine Picture
Table Major Manufacturers of Standardization Of Cancer Treatment MRNA Vaccine
Figure Individualized Cancer Treatment MRNA Vaccine Picture
Table Major Manufacturers of Individualized Cancer Treatment MRNA Vaccine
Figure Infectious Disease Treatment MRNA Vaccine Picture
Table Major Manufacturers of Infectious Disease Treatment MRNA Vaccine
Figure Infection Prevention MRNA Vaccine Picture
Table Major Manufacturers of Infection Prevention MRNA Vaccine
Figure mRNA Vaccines & Therapeutics Sales Market Share by Applications in 2017
Figure Infectious Disease Picture
Figure Cancer Picture
Figure Other Picture
Figure United States mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Canada mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Germany mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure France mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure UK mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Russia mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Italy mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure China mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Japan mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Korea mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure India mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Table Moderna Therapeutics Headquarter, Established, Main Business and Finance Overview (2017)
Table Moderna Therapeutics mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
Table Moderna Therapeutics mRNA Vaccines & Therapeutics Product
Table Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Moderna Therapeutics mRNA Vaccines & Therapeutics Sales Market Share in 2017
Figure Global Moderna Therapeutics mRNA Vaccines & Therapeutics Revenue Market Share in 2017
Table CureVac Headquarter, Established, Main Business and Finance Overview (2017)
Table CureVac mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
Table CureVac mRNA Vaccines & Therapeutics Product
Table CureVac mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global CureVac mRNA Vaccines & Therapeutics Sales Market Share in 2017
Figure Global CureVac mRNA Vaccines & Therapeutics Revenue Market Share in 2017
Table Translate Bio Headquarter, Established, Main Business and Finance Overview (2017)
Table Translate Bio mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
Table Translate Bio mRNA Vaccines & Therapeutics Product
Table Translate Bio mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Translate Bio mRNA Vaccines & Therapeutics Sales Market Share in 2017
Figure Global Translate Bio mRNA Vaccines & Therapeutics Revenue Market Share in 2017
Table BioNTech Headquarter, Established, Main Business and Finance Overview (2017)
Table BioNTech mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
Table BioNTech mRNA Vaccines & Therapeutics Product
Table BioNTech mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global BioNTech mRNA Vaccines & Therapeutics Sales Market Share in 2017
Figure Global BioNTech mRNA Vaccines & Therapeutics Revenue Market Share in 2017
Table Sangamo Therapeutics Headquarter, Established, Main Business and Finance Overview (2017)
Table Sangamo Therapeutics mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
Table Sangamo Therapeutics mRNA Vaccines & Therapeutics Product
Table Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales Market Share in 2017
Figure Global Sangamo Therapeutics mRNA Vaccines & Therapeutics Revenue Market Share in 2017
Table Argos Therapeutics Headquarter, Established, Main Business and Finance Overview (2017)
Table Argos Therapeutics mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
Table Argos Therapeutics mRNA Vaccines & Therapeutics Product
Table Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Argos Therapeutics mRNA Vaccines & Therapeutics Sales Market Share in 2017
Figure Global Argos Therapeutics mRNA Vaccines & Therapeutics Revenue Market Share in 2017
Table In-Cell-Art Headquarter, Established, Main Business and Finance Overview (2017)
Table In-Cell-Art mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
Table In-Cell-Art mRNA Vaccines & Therapeutics Product
Table In-Cell-Art mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global In-Cell-Art mRNA Vaccines & Therapeutics Sales Market Share in 2017
Figure Global In-Cell-Art mRNA Vaccines & Therapeutics Revenue Market Share in 2017
Table eTheRNA Headquarter, Established, Main Business and Finance Overview (2017)
Table eTheRNA mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
Table eTheRNA mRNA Vaccines & Therapeutics Product
Table eTheRNA mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global eTheRNA mRNA Vaccines & Therapeutics Sales Market Share in 2017
Figure Global eTheRNA mRNA Vaccines & Therapeutics Revenue Market Share in 2017
Table Ethris Headquarter, Established, Main Business and Finance Overview (2017)
Table Ethris mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
Table Ethris mRNA Vaccines & Therapeutics Product
Table Ethris mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Ethris mRNA Vaccines & Therapeutics Sales Market Share in 2017
Figure Global Ethris mRNA Vaccines & Therapeutics Revenue Market Share in 2017
Table Tiba Biotechnology Headquarter, Established, Main Business and Finance Overview (2017)
Table Tiba Biotechnology mRNA Vaccines & Therapeutics Production Bases, Sales Regions and Major Competitors
Table Tiba Biotechnology mRNA Vaccines & Therapeutics Product
Table Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Tiba Biotechnology mRNA Vaccines & Therapeutics Sales Market Share in 2017
Figure Global Tiba Biotechnology mRNA Vaccines & Therapeutics Revenue Market Share in 2017
Table Global mRNA Vaccines & Therapeutics Sales by Manufacturer (2016-2017)
Figure Global mRNA Vaccines & Therapeutics Sales Market Share by Manufacturer in 2016
Figure Global mRNA Vaccines & Therapeutics Sales Market Share by Manufacturer in 2017
Table Global mRNA Vaccines & Therapeutics Revenue by Manufacturer (2016-2017)
Figure Global mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturer in 2016
Figure Global mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturer in 2017
Table Global mRNA Vaccines & Therapeutics Price by Manufacturer (2016-2017)
Figure Top 3 mRNA Vaccines & Therapeutics Manufacturer (Revenue) Market Share in 2017
Figure Top 6 mRNA Vaccines & Therapeutics Manufacturer (Revenue) Market Share in 2017
Figure Global mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure Global mRNA Vaccines & Therapeutics Revenue and Growth Rate (2013-2018)
Table Global mRNA Vaccines & Therapeutics Sales by Regions (2013-2018)
Table Global mRNA Vaccines & Therapeutics Sales Market Share by Regions (2013-2018)
Table Global mRNA Vaccines & Therapeutics Revenue by Regions (2013-2018)
Figure Global mRNA Vaccines & Therapeutics Revenue Market Share by Regions in 2013
Figure Global mRNA Vaccines & Therapeutics Revenue Market Share by Regions in 2017
Figure North America mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure North America mRNA Vaccines & Therapeutics Revenue and Growth Rate (2013-2018)
Figure Europe mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure Europe mRNA Vaccines & Therapeutics Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)
Figure Asia-Pacific mRNA Vaccines & Therapeutics Revenue and Growth Rate (2013-2018)
Figure South
  • Global Veterinary Healthcare Product Market Insights, Forecast to 2025
    Published: 16-Nov-2018        Price: US 3900 Onwards        Pages: 108
    This report studies the global market size of Veterinary Healthcare Product in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Veterinary Healthcare Product in these regions. This research report categorizes the global Veterinary Healthcare Product market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, f......
  • Global Amiodarone Market Insights, Forecast to 2025
    Published: 16-Nov-2018        Price: US 3900 Onwards        Pages: 112
    Amiodarone is an antiarrhythmic medication used to treat and prevent a number of types of irregular heartbeats. This includes ventricular tachycardia (VT), ventricular fibrillation (VF), and wide complex tachycardia, as well as atrial fibrillation and paroxysmal supraventricular tachycardia. In 2017, the global Amiodarone market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and pro......
  • Global Sotalol Market Insights, Forecast to 2025
    Published: 16-Nov-2018        Price: US 3900 Onwards        Pages: 112
    Sotalol is a medication used to treat abnormal heart rhythms. Sotalol is a non-selective competitive beta-adrenergic receptor blocker that also exhibits Class III antiarrhythmic properties. In 2017, the global Sotalol market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Sotalol market based on company, product type, application and key regions. ......
  • Global Bisoprolol Market Insights, Forecast to 2025
    Published: 16-Nov-2018        Price: US 3900 Onwards        Pages: 111
    Bisoprolol is a medication most commonly used for heart diseases. This specifically includes high blood pressure, chest pain from not enough blood flow to the heart, and heart failure. It is taken by mouth. In 2017, the global Bisoprolol market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Bisoprolol market based on company, product type, application and......
  • Global Fiber Supplements Market Insights, Forecast to 2025
    Published: 16-Nov-2018        Price: US 3900 Onwards        Pages: 99
    This report studies the global market size of Fiber Supplements in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Fiber Supplements in these regions. This research report categorizes the global Fiber Supplements market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opport......
  • Global PVA Embolization Particles Market Insights, Forecast to 2025
    Published: 16-Nov-2018        Price: US 3900 Onwards        Pages: 110
    Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells. In 2017, the global PVA Embolization Particles market size was xx million US$ and is forecast to xx million US in 202......
  • Global Fiber Supplements Powder Market Insights, Forecast to 2025
    Published: 16-Nov-2018        Price: US 3900 Onwards        Pages: 93
    This report studies the global market size of Fiber Supplements Powder in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Fiber Supplements Powder in these regions. This research report categorizes the global Fiber Supplements Powder market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, m......
  • Global Fiber Supplements Capsule Market Insights, Forecast to 2025
    Published: 16-Nov-2018        Price: US 3900 Onwards        Pages: 91
    This report studies the global market size of Fiber Supplements Capsule in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Fiber Supplements Capsule in these regions. This research report categorizes the global Fiber Supplements Capsule market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends......
  • Global Fiber Supplements Chewable Tablets Market Insights, Forecast to 2025
    Published: 16-Nov-2018        Price: US 3900 Onwards        Pages: 94
    This report studies the global market size of Fiber Supplements Chewable Tablets in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Fiber Supplements Chewable Tablets in these regions. This research report categorizes the global Fiber Supplements Chewable Tablets market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share,......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs